Last edition
News about "generic drug development"
Granules Gains First-to-File Status for Ruxolitinib ER Tablets
Granules India has filed a Paragraph IV certification for Ruxolitinib Extended-Release (ER) Tablets, and may qualify for first-to-file status.
Generic Drug Development | 09/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members